Oncodesign announces the appointment of Aline Aubertin as an independent director of the Board of Directors

Oncodesign strenghens its Board by appointing Aline Aubertin as new independent director.

Find out how we built our logo!

Oncodesign Find out how we built our logo! trajectory DNA innovation...green and bleue pharma colors Find out how we built our logo!

Brand new logo for Oncodesign

Brand new logo for Oncodesign. New graphic identity with evolutive look & feel approach... First element of our new logo.

[FR] Oncodesign a peut-être découvert la molécule qui va lui faire retrouver les faveurs de la Bourse

[FR] Oncodesign : un accord avec Servier dans Parkinson relance Oncodesign en Bourse

[FR] Hybrid business model guarantees substainable and healthy growth

[FR] Oncodesign: Année charnière avant un nouveau cycle

Service partnership agreement between Oncodesign and Galderma

Press Release: Multi-year service contract: design and discover new drug candidates in dermatology - Galderma.

Centre Georges François Leclerc Presents the Detailed Results of the First Two Stages of its Clinical Study in Lung Cancer at the EANM Congress

Presentation of detailed results from the first two stages of the clinical trial in lung cancer | 31st EANM1 | 2018.

Precision medicine: Cap Digital and Medicen Paris-Region team-up with Oncodesign, Servier and Intersystems on Hu-PreciMED

Hu-PreciMED project will gear French precision medicine industry towards discovering new diagnostic approaches & novel therapeutic treatments.

Oncodesign furthers its cooperation with Eisai, started 12 years ago

This services agreement aims to evaluate the anti-tumor efficacy of Eisai new compounds...

Very strong revenue growth of 58% to €9.2 million in the first half of 2018